U.S. Pharma Stock News

In early May 2026, Wyndham Hotels & Resorts launched a native app within ChatGPT that lets travelers explore and book its roughly 8,400 hotels through conversational, visual search, extending years of cloud and AI investment across its franchise network. A particularly interesting angle is how Wyndham’s AI stack, from call-center tools to its Wyndham Connect platform, is already generating measurable incremental revenue and efficiency gains for hotel owners, turning innovation spending into...

Bath & Body Works has already launched a limited-edition Star Wars: The Mandalorian and Grogu collection, featuring three new franchise-inspired fragrances across body care, home fragrance, candles and accessories in the US and Canada, with international markets to follow by the end of 2026. The collaboration with Disney extends Bath & Body Works’ broader brand partnership strategy, using cinematic storytelling and loyalty-member exclusives to keep customers emotionally connected to its...

AngloGold Ashanti (NYSE:AU) capped FY 2025 with fourth quarter revenue of US$3.1b and Basic EPS of US$1.68, rounding out a trailing twelve month run of US$9.9b in revenue and Basic EPS of US$5.19. Over the past six reported quarters, revenue has moved from US$1.5b in Q3 2024 to US$3.1b in Q4 2025, while quarterly Basic EPS stepped from US$0.53 to US$1.68 as net income excluding extra items shifted from US$223m to US$855m. With trailing net profit margins sitting at 26.6% compared with 17.3% a...

nCino (NCNO) shares are back in focus after Raiffeisenbankengruppe Oesterreich selected the company’s platform to manage its entire corporate lending lifecycle across current account credit, term loans, and contingent business limits. See our latest analysis for nCino. The latest Raiffeisenbankengruppe Oesterreich win comes as nCino’s share price return over the past year and year to date has been weak. However, recent 7 day and 1 day gains hint at slightly improving short term momentum...

Annaly Capital Management (NLY) is back in focus after BofA Securities highlighted the stock as undervalued and the company declared fresh preferred stock dividends that underline its ongoing emphasis on income distribution. See our latest analysis for Annaly Capital Management. That focus on income distribution and BofA Securities viewing Annaly as undervalued comes after a mixed price pattern, with a 5.42% 1 month share price return but a slightly negative year to date move. At the same...

If you are wondering whether Carpenter Technology's recent share price puts the stock on sale or already prices in a lot of optimism, the valuation story is worth a closer look. At a last close of US$445.14, the stock shows returns of 4.0% over 7 days, 13.0% over 30 days, 31.6% year to date and 113.4% over 1 year, with a very large 3 year and 5 year return profile. Recent coverage has focused on Carpenter Technology's role in capital goods and aerospace related markets, with attention on how...

Popular, Inc. recently declared a quarterly common stock dividend of US$0.75 per share and approved monthly dividends on its preferred and trust preferred securities, alongside reporting quarterly net income of US$245.7 million and strong deposit growth as of March 31, 2026. This combination of cash returns to shareholders, higher earnings compared with a year earlier, and a Common Equity Tier 1 ratio of 15.92% underscores Popular’s current capital strength and capacity to distribute capital...

Investors may be asking whether Principal Financial Group at around US$100 per share is offering fair value or a potential mispricing opportunity right now. The stock has recently seen a 0.9% decline over 7 days, compared with stronger returns of 9.9% over 30 days, 11.9% year to date, 31.8% over 1 year, 62.3% over 3 years and 83.4% over 5 years. Recent coverage has focused on how investors are reassessing insurers like Principal Financial Group in light of broader sector trends and shifting...

Paramount Skydance (NasdaqGS:PSKY) is pursuing a transformative acquisition of Warner Bros. Discovery, with new information emerging on regulatory hurdles and timing. Regulators, including state attorneys general and the FCC, are reviewing the deal, with questions around competition and foreign ownership. The company plans to merge Pluto TV into Paramount+ this summer and aims for a theatrical slate of about 30 films per year. A new first-look film partnership with Warner Music Group is set...

Stock performance snapshot MBX Biosciences (MBX) has caught investor attention recently, with the stock showing an 8.1% move in the last day and a 14.9% gain over the past month, alongside a 1-year total return near 196%. That kind of run, combined with a market value around US$1.53b and clinical stage programs in endocrine and metabolic disorders, puts the spotlight on how much future progress in its pipeline might already be reflected in the current share price. See our latest analysis for...

In early May 2026, Galaxy Digital Inc. filed a US$500 million at-the-market follow-on offering and a roughly US$7.77 billion shelf registration covering up to 265,061,636 Class A shares plus a broad mix of other securities. Just days earlier, State Street Investment Management and Galaxy Asset Management launched the State Street Galaxy Onchain Liquidity Sweep Fund on Solana, underscoring Galaxy’s role in bringing tokenized cash management and stablecoin-based fund access to institutional...

CDW (NasdaqGS:CDW) has launched an AI first program called "Geared for Growth" across its operations and go to market model. The initiative seeks up to US$200 million in annual run rate savings targeted for 2027 to 2028. The program focuses on embedding AI into internal processes and customer facing activities to improve productivity and efficiency. CDW is a technology solutions provider, so an AI first shift sits directly in the flow of what customers are asking for across infrastructure,...

Why Proto Labs Stock Is Drawing Attention Now Proto Labs (PRLB) is back on many investors’ radar after a recent share price move, with the stock showing a return of about 18% over the past month and 33% year to date. See our latest analysis for Proto Labs. The recent 1 month share price return of 18.5% and year to date share price return of 32.8% come on top of a 1 year total shareholder return of 69.6%, suggesting momentum has been building rather than fading. If Proto Labs has caught your...

Wondering if Plains All American Pipeline at around US$22 is still offering value, or if most of the opportunity is already priced in. The stock last closed at US$22.09, with a 4% decline over the past week, a 0.7% decline over the past month, a 21.3% gain year to date and a 41.7% return over the past year. Recent coverage around Plains All American Pipeline has focused on its position within the energy infrastructure space and how investors are weighing income potential against exposure to...

Wondering if Paycom Software at around US$138 a share is a bargain or a value trap? This article walks through what the current price actually implies. The stock has shown a 9.2% return over the last 7 days and 11.4% over the last 30 days. Yet year to date it sits at a 9.2% loss and a 44.0% loss over the past year, which naturally raises questions about risk and potential recovery. Recent coverage has focused on how Paycom Software fits into the broader professional services and software...

VICI Properties (VICI) just posted first quarter 2026 results, reporting revenue of US$1.02b and net income of US$872.39m, and raised full year AFFO guidance on the back of acquisitions and lending activity. See our latest analysis for VICI Properties. At a share price of US$28.79, VICI’s 30 day share price return of 3.45% contrasts with a 1 year total shareholder return of 3.24% decline. This suggests recent momentum is improving after a softer year, as investors weigh the raised AFFO...

Multiple securities fraud class action lawsuits have been filed against Pinterest (NYSE:PINS), targeting the company and certain executives. The suits claim Pinterest misled investors about advertising revenue pressures, the effects of U.S. tariffs, and upcoming restructuring plans. These cases are at an early stage, with a lead plaintiff deadline still pending. Pinterest runs a visual discovery platform that connects users with products and ideas, and its business model relies heavily on...

Schrödinger (SDGR) is back in focus after first quarter 2026 results combined a reported earnings miss with 12% growth in Annual Contract Value, along with fresh attention on its upcoming Bunsen AI co-scientist launch. See our latest analysis for Schrödinger. Recent trading reflects this renewed interest, with a 1 month share price return of 16.59% and 7 day share price return of 11.04%. However, the year to date share price return of negative 26.14% and 1 year total shareholder return of...

ACM Research (ACMR) opened 2026 with Q1 revenue of US$231.3 million and basic EPS of US$0.26, alongside trailing twelve month revenue of US$960.2 million and EPS of US$1.40 that frame the latest quarterly print. Over the past six quarters, the company has seen quarterly revenue range from US$172.3 million to US$269.2 million and basic EPS move between US$0.12 and US$0.56, giving investors a clear view of how top line and per share earnings have tracked into the current TTM profile. With...

CG Oncology (CGON) has just closed out FY 2025 with Q4 revenue of US$2.3 million and a basic EPS loss of US$0.52, alongside a net income loss of US$41.3 million, as the company continues to invest heavily in its pipeline. Over the last twelve months, revenue has summed to US$4.0 million and basic EPS has come in at a loss of US$2.08. This gives investors a clear view of a business that is still in a development phase and running with intentionally thin margins while it pushes its late stage...

If you are wondering whether Envista Holdings at US$24.29 offers good value or is already fully priced, the recent share performance gives you a useful starting point. The stock has pulled back 6.4% over the last 7 days and 4.0% over the last 30 days. It sits 12.0% higher year to date and 36.7% above where it was a year ago, while the 3 year and 5 year returns of 26.7% and 44.7% highlight a tougher longer term journey. Recent coverage has focused on Envista Holdings as a dental equipment and...

Earnings picture during a key regulatory phase Vera Therapeutics (VERA) reported a first quarter net loss of US$121.03 million, compared with US$51.69 million a year earlier, as it pushes atacicept toward potential approval for IgA nephropathy. Basic and diluted loss per share from continuing operations came in at US$1.69, versus US$0.81 in the prior year period. This provides a snapshot of how much capital the company is currently investing ahead of the July 7, 2026 FDA decision. See our...

What PNC’s Recent Returns Tell You PNC Financial Services Group (PNC) has moved in different directions across timeframes, with a 1 day return of about a 1.4% decline, losses over the past 3 months, and a 1 year total return of 35.9%. See our latest analysis for PNC Financial Services Group. Recent share price moves have cooled slightly, with a 30 day share price return of 2.5% against a 90 day share price return of a 9.6% decline, while the 1 year total shareholder return of 36.0% and 3...

Wondering if Labcorp Holdings at around US$258 a share still offers value, or if most of the opportunity is already priced in? This article walks through the key signals you can use to judge that for yourself. The stock has been fairly steady over the last week with a 0.5% return, has a 4.1% decline over the past month, yet sits on a 4.8% return over 1 year and 41.6% over 3 years. This raises the question of whether the current price reflects the business fundamentals. Recent headlines...